Bulletin
Investor Alert

New York Markets After Hours

Enanta Pharmaceuticals Inc.

NAS: ENTA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209139157/composite

$

44.83

Change

0.00 0.00%

Volume

Volume 979

Sep 29, 2020, 4:04 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209139157/composite

Today's close

$ 44.15

$ 44.83

Change

+0.68 +1.54%

Day low

Day high

$43.88

$45.06

Open
Open: 44.24

52 week low

52 week high

$38.40

$67.88

Open

Market cap

$886.19M

Average volume

169,481

P/E ratio

610.76

Rev. per Employee

$2.11M

EPS

0.07

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/enta

MarketWatch News on ENTA

  1. Enanta Pharmaceuticals downgraded to perform from outperform at Oppenheimer

    7:21 a.m. Aug. 8, 2018

    - Tomi Kilgore

  2. Enanta Pharmaceuticals downgraded to neutral from overweight at J.P. Morgan

    8:55 a.m. Feb. 8, 2018

    - Tomi Kilgore

  3. Enanta Pharmaceuticals downgraded to sector perform vs outperform at RBC

    8:53 a.m. Jan. 2, 2018

    - Ciara Linnane

  4. These 55 stocks have at least doubled since Trump was elected

    4:04 p.m. Dec. 19, 2017

    - Philip van Doorn

  5. Gilead Sciences: Still Dominating Hepatitis C But…

    3:24 p.m. Aug. 17, 2016

    - Barrons Blogs

  6. Enanta Pharmaceuticals upgraded to overweight from equal weight at Barclays

    12:08 p.m. Oct. 23, 2015

    - Tomi Kilgore

  7. Health-Care Firestorm Engulfs Hospitals, AbbVie

    9:52 a.m. Oct. 23, 2015

    - Barrons Blogs

  8. AbbVie’s Pain is Gilead’s Gain, But is It an Overreaction?

    4:19 p.m. Oct. 22, 2015

    - Barrons Blogs

  9. More Pain For Biotech ETFs

    10:19 a.m. Oct. 6, 2015

    - Barrons Blogs

  10. 10 healthy, growing companies that can help you beat the stock market

    9:33 a.m. Sept. 16, 2015

    - Philip van Doorn

  11. 10 cheapest stocks in the Nasdaq’s hottest sector

    5:25 p.m. Feb. 25, 2015

    - Philip van Doorn

  12. Gilead Walloped by Lower Pricing View on Hepatitis C

    11:59 a.m. Feb. 10, 2015

    - Barron's Online

  13. Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade

    4:28 p.m. Feb. 6, 2015

    - Barrons Blogs

  14. Don’t look for pricey hepatitis drugs to come down

    3:32 p.m. Jan. 13, 2015

    - Russ Britt

  15. FDA approves AbbVie’s hepatitis treatment

    4:33 p.m. Dec. 19, 2014

    - Peter Loftus

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/enta

Other News on ENTA

  1. Enanta initiates early-stage NASH study with EDP-297

    10:06 a.m. Sept. 14, 2020

    - Seeking Alpha

  2. Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin

    8:30 a.m. Aug. 15, 2020

    - Seeking Alpha

  3. New Strong Sell Stocks for August 6th

    8:13 a.m. Aug. 6, 2020

    - Zacks.com

  4. Notable earnings after Tuesday's close

    5:35 p.m. Aug. 3, 2020

    - Seeking Alpha

  5. Enanta Pharma Q3 2020 Earnings Preview

    5:35 p.m. Aug. 3, 2020

    - Seeking Alpha

  6. 10-Q: ENANTA PHARMACEUTICALS INC

    4:12 p.m. May 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  7. Loading more headlines...
/news/pressrelease/company/us/enta

Press Releases on ENTA

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.